Evidence map›Paper›PMID 33354827›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2021

Factors associated with potential over- and undertreatment of hyperglycaemia and annual measurement of HbA

Anh T Tran, Tore J Berg, Ibrahimu Mdala, Bjørn Gjelsvik, John G Cooper, Sverre Sandberg, Tor Claudi, Anne K Jenum

Open access · bronzeAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Anh T TranDepartment of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.ORCID 0000-0003-4455-8172
Tore J BergInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Ibrahimu MdalaDepartment of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
Bjørn GjelsvikDepartment of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
John G CooperNorwegian Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital, Bergen, Norway.
Sverre SandbergNorwegian Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital, Bergen, Norway.
Tor ClaudiDepartment of Medicine, Nordland Hospital, Bodø, Norway.
Anne K JenumDepartment of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
University of Oslo · NOHaukeland University Hospital · NONordland Hospital · NOOslo University Hospital · NOStavanger University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo identify individual and general practitioner (GP) characteristics associated with potential over- and undertreatment of hyperglycaemia in type 2 diabetes and with HbA

methodsA cross-sectional study that included 10233 individuals with type 2 diabetes attending 282 GPs. Individuals with an HbA

resultsOverall, 4.1% were potentially overtreated, 7.8% were potentially undertreated and 11% did not have HbA

conclusionPotential overtreatment in elderly individuals with type 2 diabetes was relatively low. Nevertheless, appropriate de-intensification or intensification of treatment and regular HbA

Indexed as

General PracticeAgedBiomarkersBlood GlucoseCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGlycated HemoglobinHumansHyperglycemiaHypoglycemic AgentsIncidenceInsulinMaleMiddle AgedBiomarkersBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulinfamily medicinegeneral practiceHbA1covertreatmenttype 2 diabetesundertreatment

Identifiers

PMID33354827
PMCPMC8359382
OpenAlexW3117383591

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.